Table 1 Age, sex, and disease duration since diagnosis
Rheumatoid arthritisa | Psoriatic arthritis | Ankylosing spondylitis | ||||
|---|---|---|---|---|---|---|
Placebo n = 450 | IFX n = 1061 | Placebo n = 100 | IFX n = 100 | Placebo n = 78 | IFX n = 201 | |
Sex, % women | 82% | 78% | 49% | 29% | 13% | 22% |
Age (years)b | 52.2 (12.3) | 51.8 (12.4) | 46.5 (11.3) | 47.1 (12.8) | 40.3 (9.4) | 39.6 (10.6) |
Range | (19, 85) | (18, 89) | (24, 71) | (18, 80) | (20, 74) | (18, 71) |
Disease duration (years)b | 9.9 (8.8) | 10.3 (9.1) | 7.5 (7.8) | 8.4 (7.2) | 11.9 (8.0) | 10.1 (8.7) |
Range | (0.3, 41.5) | (0.3, 55.5) | (0.3, 38.5) | (0.4, 29.2) | (0.3, 31.6) | (0.3, 41.1) |